Manifold Bio
Signal active
Organization
Contact Information
Overview
Manifold Bio is a biotechnology company that features a platform that enables multiplexed quantitation of protein therapeutic designs, generating unprecedented data throughout the drug development process to unlock measurement-driven design. The company is building a protein barcoding platform to bring the power of multiplexed measurement to the development of protein therapeutics.
It was founded in 2020 and headquartered in Boston, Massachusetts.
About
Industries
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Founded
2020
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Manifold Bio headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Therapeutics sector. The company focuses on Biotechnology and has secured $2.2B in funding across 48 round(s). With a team of 11-50 employees, Manifold Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Manifold Bio, raised $40.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
8
Lead Investors
0
Total Funding Amount
$45.4M
Details
3
Manifold Bio has raised a total of $45.4M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Seed | 5.4M | ||
| 2020 | Seed | |||
| 2022 | Early Stage Venture | 40.0M |
Investors
Manifold Bio is funded by 19 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Section 32 | - | FUNDING ROUND - Section 32 | 40.0M |
| Fifty Years | - | FUNDING ROUND - Fifty Years | 40.0M |
| Manifold Bio | - | FUNDING ROUND - Manifold Bio | 40.0M |
| FAST — by GETTYLAB | - | FUNDING ROUND - FAST — by GETTYLAB | 40.0M |
Recent Activity
There is no recent news or activity for this profile.